Victory Square Announces U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Platform
Why this matters
Commercial real estate continues to digest a multi-year reset in cost of capital. Transaction velocity is below the 2019-2021 trend but improving, cap rates have stabilized across most stabilized property types, and the bid-ask gap has narrowed materially in the past two quarters. Sponsors with permanent capital and operating platforms have an advantage in the current execution environment. The next twelve months will continue to reward underwriting discipline and operational sophistication over balance-sheet aggression.
Editorial analysis · Real Estate Trail Editorial
Milestone advances portfolio company's intellectual-property foundation for InsuTab™ and BuccaGLP™, supported by an exclusive worldwide UBC licence and Hydreight's previously disclosed U.S. distribution rights VANCOUV…
External link. Real Estate Trail does not republish source content.
More from the wire
Pivix Launches Monoline Commercial Property Program
Compass, Qualia expand title and escrow partnership
Consolidation will replace separate systems Compass inherited following its merger with Anywhere Real Estate
CPP Investments, Temasek back Nuveen’s Australian real estate debt strategy
Vesta raises $30M in Series B funding to expand AI-native LOS
Among lender investors in the platform, Pennymac saw a 25% drop in origination costs and 50% LO efficiency gains after moving to Vesta